Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Gives Congress Reprieve On Deadline For Passing User Fee Bill

Jul 26 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

White House Slams Generic Exclusivity Provisions In User Fee Bill

Jul 14 2017

Gottlieb Distances Himself From Trump's User-Fee Heavy Budget

May 26 2017

User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases

Jul 13 2017

FDA's No Comment On Budget Plans Leaves Awkward Void

Mar 24 2017

PDUFA Fees Forced Down For FY 2017 Due To Refund Provision

Jul 27 2016

Congress Approves FDA Reform/User Fee Bill In The Nick Of Time

Sep 24 2007

Additional Topics

United States FDA Legislation Regulation Generic Drugs Biosimilars BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window